BR0010213A - Derivados de ciclocarbamato como moduladores de receptor de progesterona - Google Patents

Derivados de ciclocarbamato como moduladores de receptor de progesterona

Info

Publication number
BR0010213A
BR0010213A BR0010213-0A BR0010213A BR0010213A BR 0010213 A BR0010213 A BR 0010213A BR 0010213 A BR0010213 A BR 0010213A BR 0010213 A BR0010213 A BR 0010213A
Authority
BR
Brazil
Prior art keywords
substituted
alkyl
aminoalkyl
alkoxy
alkynyl
Prior art date
Application number
BR0010213-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Andrew Fensome
Puwen Zhang
Eugene A Terefenko
Horace Fletcher Iii
Jay E Wrobel
Lin Zhi
Todd K Jones
Christopher M Tegley
James P Edwards
Original Assignee
American Home Prod
Ligand Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,633 external-priority patent/US6509334B1/en
Application filed by American Home Prod, Ligand Pharm Inc filed Critical American Home Prod
Publication of BR0010213A publication Critical patent/BR0010213A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR0010213-0A 1999-05-04 2000-05-01 Derivados de ciclocarbamato como moduladores de receptor de progesterona BR0010213A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18301299P 1999-05-04 1999-05-04
US09/552,633 US6509334B1 (en) 1999-05-04 2000-04-19 Cyclocarbamate derivatives as progesterone receptor modulators
PCT/US2000/011822 WO2000066571A1 (en) 1999-05-04 2000-05-01 Cyclocarbamate derivatives as progesterone receptor modulators

Publications (1)

Publication Number Publication Date
BR0010213A true BR0010213A (pt) 2002-02-19

Family

ID=26878647

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0010213-0A BR0010213A (pt) 1999-05-04 2000-05-01 Derivados de ciclocarbamato como moduladores de receptor de progesterona

Country Status (19)

Country Link
EP (1) EP1173426A1 (cg-RX-API-DMAC10.html)
JP (1) JP2002543193A (cg-RX-API-DMAC10.html)
KR (1) KR20010114250A (cg-RX-API-DMAC10.html)
CN (1) CN1145618C (cg-RX-API-DMAC10.html)
AU (1) AU766428B2 (cg-RX-API-DMAC10.html)
BG (1) BG106079A (cg-RX-API-DMAC10.html)
BR (1) BR0010213A (cg-RX-API-DMAC10.html)
CA (1) CA2371726A1 (cg-RX-API-DMAC10.html)
CZ (1) CZ20013951A3 (cg-RX-API-DMAC10.html)
EA (1) EA004512B1 (cg-RX-API-DMAC10.html)
HU (1) HUP0201609A3 (cg-RX-API-DMAC10.html)
IL (1) IL146280A0 (cg-RX-API-DMAC10.html)
MX (1) MXPA01011286A (cg-RX-API-DMAC10.html)
NO (1) NO321361B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ515355A (cg-RX-API-DMAC10.html)
PL (1) PL351127A1 (cg-RX-API-DMAC10.html)
SG (1) SG114650A1 (cg-RX-API-DMAC10.html)
SK (1) SK15912001A3 (cg-RX-API-DMAC10.html)
TR (1) TR200103286T2 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5108506B2 (ja) * 2004-04-27 2012-12-26 ワイス・エルエルシー シアノピロール含有環式カルバメートおよびチオカルバメートビアリール、およびこれらの製造方法
US20100160304A1 (en) * 2005-01-19 2010-06-24 Dainippon Sumitomo Pharma Co., Ltd Aromatic sulfone compound as aldosterone receptor modulator
WO2009044788A1 (ja) 2007-10-05 2009-04-09 Banyu Pharmaceutical Co., Ltd. ベンゾオキサジノン誘導体
CN111925353B (zh) * 2020-08-31 2022-04-08 苏州大学附属第二医院 一种2-噻吩甲腈的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0510235A1 (en) * 1991-04-26 1992-10-28 Dong-A Pharm. Co., Ltd. Novel benzoxazine or benzothiazine derivatives and process for the preparation of the same
WO1995020389A1 (en) * 1994-01-28 1995-08-03 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
AU717251B2 (en) * 1994-12-22 2000-03-23 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
DE69724630T2 (de) * 1996-10-02 2004-07-29 Bristol-Myers Squibb Pharma Co. 4,4-disubstituierte 1,4-dihydro-2h-3,1-benzoxazin-2-one die anwendbar sind als hiv-reverstranskriptase-inhibitoren, zwischenprodukte und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
CA2371726A1 (en) 2000-11-09
NZ515355A (en) 2004-02-27
AU4688600A (en) 2000-11-17
EA004512B1 (ru) 2004-04-29
SG114650A1 (en) 2005-09-28
PL351127A1 (en) 2003-03-24
EA200101176A1 (ru) 2002-04-25
TR200103286T2 (tr) 2002-07-22
NO20015378L (no) 2002-01-03
CZ20013951A3 (cs) 2002-05-15
MXPA01011286A (es) 2003-07-14
CN1145618C (zh) 2004-04-14
BG106079A (en) 2002-05-31
SK15912001A3 (sk) 2002-06-04
NO20015378D0 (no) 2001-11-02
HUP0201609A2 (en) 2002-08-28
HUP0201609A3 (en) 2002-12-28
IL146280A0 (en) 2002-07-25
AU766428B2 (en) 2003-10-16
JP2002543193A (ja) 2002-12-17
CN1349517A (zh) 2002-05-15
EP1173426A1 (en) 2002-01-23
NO321361B1 (no) 2006-05-02
KR20010114250A (ko) 2001-12-31

Similar Documents

Publication Publication Date Title
BG101806A (bg) Индолови производни като антагонисти на 5-нт рецептори
EA200600811A1 (ru) НОВЫЕ ПРОИЗВОДНЫЕ ТЕТРАГИДРОСПИРО {ПИПЕРИДИН-2,7'-ПИРРОЛО [3,2-b]ПИРИДИНА} И НОВЫЕ ПРОИЗВОДНЫЕ ИНДОЛА, ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАССТРОЙСТВ, СВЯЗАННЫХ С 5-HT-РЕЦЕПТОРОМ
NO20070336L (no) Indolderivater som histamin-reseptorantagonister
BR0306150A (pt) Composto, uso de um composto, e, composição farmacêutica
BR0306208A (pt) Compostos de dibenzilamina e seu uso farmacêutico
NO20004778L (no) Amidderivater og nociceptin antagonister
BRPI0414450A (pt) derivados de diazabicicloalcano substituìdos como ligandos nos receptores de alfa 7 acetilcolina nicotìnica
BR0109855A (pt) Derivados de 8-isoquinolinxantina e 8-quinolixantina como inibidores de pde 5
NO20050007L (no) 1-Heterosyklylalkyl-3-sulfonylazaindol eller -azaindazolderivater som 5-hydroksytryptamin-6 ligander
DE60232029D1 (de) N-ä1h-indol-5-ylünaphthalin-1-sulphonamid-derivate und verwandte verbindungen als serotonin 5-ht6 rezeptor antagonisten zur behandlung von erkrankungen des zentralen nervensystems
WO2000066564A8 (en) Benzimidazolones and analogues and their use as progesterone receptor ligands
EA201001178A1 (ru) 2-АЛКИЛАМИНО-3-АРИЛСУЛЬФОНИЛ-ЦИКЛОАЛКАНО[e ИЛИ d]ПИРАЗОЛО[1,5-a]ПИРИМИДИНЫ - АНТАГОНИСТЫ СЕРОТОНИНОВЫХ 5-НТРЕЦЕПТОРОВ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
BR0206633A (pt) Derivados de 1-aril- ou 1-arilsulfonilbenzazol como ligandos de 5-hidroxitriptamina-6
BR9915475A (pt) Derivados da quinolina-4-carboxamida comoantagonistas dos receptores de nk-3 e nk-2
BR0215151A (pt) Derivados de azaindolilalquilamina como ligandos de 5-hidroxitriptamina-6
UY26048A1 (es) Derivados de piridopiranoacepinas, su preparacion y su aplicacion terapeutica
BR0315056A (pt) Compostos tendo tanto atividade agonista nicotìnica de alfa7 quanto atividade antagonista de 5ht3 para o tratamento de doenças do sistema nervoso central
BR0010214A (pt) Derivados de ciclotiocarbamato como moduladores de receptores de progesterona
BR9809652A (pt) Derivados de quinolina-4-carboxamida como antagonistas de receptor nk-2 e nk-3
BRPI0411285A (pt) composto, processo para preparar um composto formulação farmacêutica, uso de um composto, e, método de prevenção ou tratamento de distúrbios
ATE512142T1 (de) Pyrimidin- und chinazolinderivate als modulatoren der somatostatin-rezeptor aktivität
BR0214695A (pt) Derivados de pirazol com anel fundido
ES2154605A1 (es) Nuevos derivados mixtos de bencimidazol-arilpiperazina con afinidad por los receptores serotoninergicos 5-ht1a y 5-ht3
NO963331L (no) 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister
NO308658B1 (no) Sammenføyde isoquinoliner som dopamin-reseptor-ligander

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE ACORDO COM OS ARTIGOS 8O, 11, 13, 24 E 25 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.